Landmark Analysis at the 25-Year Landmark Point

被引:400
作者
Dafni, Urania [1 ,2 ]
机构
[1] Univ Athens, Dept Nursing, Div Publ Hlth, Lab Biostat, Athens 11527, Greece
[2] Frontier Sci Fdn, Athens, Greece
关键词
clinical trials; observational studies; prognostic factors; time-to-event outcome; time-varying covariate; DRUG-ELUTING STENTS; CLINICAL-TRIALS; CARDIAC TRANSPLANTATION; TUMOR RESPONSE; SURVIVAL; TIME; OUTCOMES; EVENT; ANGIOGRAPHY; GUIDELINES;
D O I
10.1161/CIRCOUTCOMES.110.957951
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
This statistical primer presents the landmark analysis method, exploring its appropriate use and interpretation while recognizing its limitations. This observational method is used for comparing time-to-event outcome between groups determined during study follow-up. The goal of the landmark method is to estimate in an unbiased way the time-to-event probabilities in each group conditional on the group membership of patients at a specific time point, the landmark time. The need that led to its development, the impact of the method, and its pros and cons, along with available alternative approaches, are presented. Simulations explore its performance, using realistic parameters from a recent cardiovascular study. As long as the limitations of the method are recognized and the interpretation of its results clearly reflect their "conditional" nature, landmark analysis, 25 years from its introduction, can still be of value. (Circ Cardiovasc Qual Outcomes. 2011; 4: 363-371.)
引用
收藏
页码:363 / U216
页数:49
相关论文
共 30 条
  • [1] Analysis of survival by tumor response and other comparisons of time-to-event by outcome variables
    Anderson, James R.
    Cain, Kevin C.
    Gelber, Richard D.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (24) : 3913 - 3915
  • [2] ANALYSIS OF SURVIVAL BY TUMOR RESPONSE
    ANDERSON, JR
    CAIN, KC
    GELBER, RD
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1983, 1 (11) : 710 - 719
  • [3] Analysis of outcome by response flawed
    Anderson, JR
    Neuberg, DS
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (31) : 8122 - 8123
  • [4] ANDERSON JR, 1986, J CLIN ONCOL, V4, P115, DOI 10.1200/JCO.1986.4.1.115
  • [5] [Anonymous], 2005, R LANG ENV STAT COMP
  • [6] BERTINO JR, 1986, J CLIN ONCOL, V4, P1
  • [7] Buyse M, 1996, STAT MED, V15, P2797, DOI 10.1002/(SICI)1097-0258(19961230)15:24<2797::AID-SIM290>3.0.CO
  • [8] 2-V
  • [9] Impact of Age and Medical Comorbidity on the Effectiveness of Implantable Cardioverter-Defibrillators for Primary Prevention
    Chan, Paul S.
    Nallamothu, Brahmajee K.
    Spertus, John A.
    Masoudi, Frederick A.
    Bartone, Cheryl
    Kereiakes, Dean J.
    Chow, Theodore
    [J]. CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES, 2009, 2 (01): : 16 - U38
  • [10] CARDIAC TRANSPLANTATION IN MAN .6. PROGNOSIS OF PATIENTS SELECTED FOR CARDIAC TRANSPLANTATION
    CLARK, DA
    STINSON, EB
    GRIEPP, RB
    SCHROEDER, JS
    SHUMWAY, NE
    HARRISON, DC
    [J]. ANNALS OF INTERNAL MEDICINE, 1971, 75 (01) : 15 - +